LCN2 and liver dysplastic nodule: suggested three novel potential biomarkers for early detection of DN in T2DM patients’ serum: neutrophil gelatinase-associated lipocalin (NGAL), beta-trace protein (beta TP), and microRNA-130b (miR-130b) (5).